.

Luke Hanoman, 28, knew that biting his nails was a bad habit, but he never realized it could kill him.

“It was a nervous thing,” the father of two from Southport, Britain, told The Mirror. “And one day I bit the skin down the side of my nail. It hurt a bit but I didn’t think anything of it.”

In the days that followed, Hanoman kept going to work despite feeling ill with flu-like symptoms and his finger became swollen.

“I started going really weird and I couldn’t focus,” he told the publication.

.
.
.
.

Experimental brain drug proves effective

What Conn eventually understood was that the pairs of mutations that controlled the expression of MYC and PTEN, when put together, also activated something called "the unfolded protein response" at cellular level.

This response allows the cancer cells to become resistant to cellular stress by lowering the levels protein synthesis. It does that by turning a protein called eIF2a, which helps to facilitate protein production, into a different kind of protein called P-eIF2a. This has the opposite effect: to downregulate synthesis.

Further analyses conducted on human prostate cancer tumors revealed that high levels of P-eIF2a were a strong predictor of negative health outcomes in patients with resilient forms of cancer.

So, the researchers decided to go ahead and test if blocking P-eIF2a production would change the cancer cells' response to cellular stress and render them vulnerable to cell death.

They collaborated with Peter Walter, also from the UCSF, whose own team of researchers found that a molecule referred to as the integrated stress response inhibitor (ISRIB) can reverse the effects of P-eIF2a.

ISRIB had not previously been considered as a useful tool in cancer treatment. Instead, Walter and his laboratory used it as a drug that could reverse the impact of severe brain damage in rodents.

The mechanism by which it does this, however, is probably by upregulating protein synthesis in affected neurons.

Free On Mobile Free On Mobile Available now for iPhone, iPad & Android
Artists & Labels Get your music heard with Radio Airplay Artists & Labels Get your music heard with Radio Airplay
© 2007-2018 jango.com